Assessing The Cost Effectiveness Of A New, First-In-Class Triple Fixed Dose Combination Therapy For COPD Patients
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.3047
https://www.valueinhealthjournal.com/article/S1098-3015(17)33382-X/fulltext
Title :
Assessing The Cost Effectiveness Of A New, First-In-Class Triple Fixed Dose Combination Therapy For COPD Patients
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)33382-X&doi=10.1016/j.jval.2017.08.3047
First page :
A647
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1349